Article and Video CATEGORIES
We're back up, so people can leave comments after these posts, register, etc.
The plan is to move over the all of the post content to the GRACE website, and then start a new forum section there, freezing the OncTalk forums so that they can be read and searched, but not added to. Instead, a very similar forum structure has been started in the GRACE website, separated by "verticals", so that questions about drug side effects can be attended to not only by me and Dr. Laskin but also Dr. McCune, a Pharm D, radiation oncology questions can be fielded by expert radiation oncologist Dr. Vivek Mehta, and other questions can be covered by the most qualified expert(s). The division by subject will also exist with the articles/blog content the faculty provide, so people can find multiple posts about radiation oncology or social work/coping with cancer all together.
I expert that there will be some tweaking to do once we move, so please provide your suggestions. We can always continue to improve it.
But expect that sometime in the next week or so you'll be directed over to the posts at GRACE instead of OncTalk, and from the OncTalk discussion forum to the forum at GRACE to add new entries. Please jump in when the time comes. We will likely auto-redirect the web browsers at some point in the future, once the kinks are ironed out (most, at least).
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…